in a double-blind , randomized trial , we tested the effectiveness of metronidazole ( 0.6 g/day ) against sulfasalazine ( 2 g/day ) in the maintenance of remission in patients with ulcerative colitis .
C0036078
sulfasalazine
C0009324
ulcerative colitis